Lv1
10 积分 2023-08-16 加入
Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial)
25天前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
25天前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
25天前
已完结
Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy
26天前
已完结
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®): Health Professional Version
1个月前
已关闭
Diagnosis and Management of Multiple Myeloma
1个月前
已完结
非甾体抗炎药相关肾损伤机制及研究进展
1个月前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
2个月前
已完结
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
2个月前
已完结
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
6个月前
已完结
皖公网安备34019202002308
